Acthar® Gel

Manufacturing · California, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

26118 Research Pl, Hayward, California, ...

Phone Number

(510) 400-0710

Revenue

$26.8 Million

Industry

Manufacturing Pharmaceuticals

About Acthar® Gel

Keenova Therapeutics plc specializes in Acthar Gel, a prescription medication approved by the FDA for treating various inflammatory and autoimmune conditions. The product is designed for patients suffering from conditions such as dermatomyositis, lupus, multiple sclerosis, and infantile spasms, among others. Keenova aims to provide resources and support for both patients and healthcare professionals to facilitate treatment access and management. Their intended clients include individuals with specific medical conditions and healthcare providers involved in patient care.Explore more
Acthar® Gel's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Acthar® Gel Org Chart

PhoneEmail
AH
United States flag for contact location.

Sales Representative

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Acthar® Gel

Compare insights from companies similar to Acthar® Gel, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Acthar® Gel

$26.8M
51-200
Private
-
-
AH
Anthony HinesSales Representative
$17.1M
51-200
Private
-
-
N/A
Illustration of an envelope

Acthar® Gel Tech Stack

A closer look at the technologies used by Acthar® Gel

Top Manufacturing Companies

Frequently Asked Questions Regarding Acthar® Gel

What is Acthar® Gel's official website?
Acthar® Gel's official website is www.acthar.com
What is Acthar® Gel's Revenue?
Acthar® Gel's revenue is $26.8 Million
What is Acthar® Gel's SIC code?
Acthar® Gel's SIC: 28,283
What is Acthar® Gel's NAICS code?
Acthar® Gel's NAICS: 32,325
How many employees does Acthar® Gel have?
Acthar® Gel has 51-200 employees
What industry does Acthar® Gel belong to?
Acthar® Gel is in the industry of: Manufacturing, Pharmaceuticals
What is Acthar® Gel competition?
Acthar® Gel top competitors include: Remicade
What companies has Acthar® Gel acquired?
Acthar® Gel has acquired the companies: Questcor Pharmaceuticals, IKARIA, Inc - now a part of Mallinckrodt Pharmaceuticals, Mallinckrodt Hospital Products, R-Tech Ueno
What technology does Acthar® Gel use?
Some of the popular technologies that Acthar® Gel uses are: reCAPTCHA, DoubleClick, PulsePoint, Google Universal Analytics
How do I contact Acthar® Gel?
Acthar® Gel contact info: Phone number: (510) 400-0710 Website: www.acthar.com
What does Acthar® Gel do?

Keenova Therapeutics plc specializes in Acthar Gel, a prescription medication approved by the FDA for treating various inflammatory and autoimmune conditions. The product is designed for patients suffering from conditions such as dermatomyositis, lupus, multiple sclerosis, and infantile spasms, among others. Keenova aims to provide resources and su... pport for both patients and healthcare professionals to facilitate treatment access and management. Their intended clients include individuals with specific medical conditions and healthcare providers involved in patient care.Read More

What are Acthar® Gel social media links?
Acthar® Gel Linkedin page Acthar® Gel Twitter page
Is Acthar® Gel a public company?
Acthar® Gel is private company therefore does not currently have an official ticker symbol
See more information about Acthar® Gel

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.